Additionally, CRISPR/Cas9 protein fused to TET1 (TET1-dCas9) increases the Forkhead Box P3 (FOXP3) expression via demethylation of their promoters in HCC202 BC cells [103]. This evidence concerns the gene TET1 and breast cancer.